Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 study (Q34618917)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 study |
scientific article |
Statements
1 reference
Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1-2 study (English)
1 reference
Andrzej Hellmann
1 reference
Jan Walewski
1 reference
Jerzy Holowiecki
1 reference
Tadeusz Robak
1 reference
Janusz Kloczko
1 reference
Bertrand Coiffier
1 reference
Stéphane Lepretre
1 reference
Lars Møller Pedersen
1 reference
Ole Gadeberg
1 reference
Marinus H J van Oers
1 reference
Nedjad Losic
1 reference
Birgitte Biilmann Rønn
1 reference
Henrik Frederiksen
1 reference
James Wooldridge
1 reference
Jørgen Petersen
1 reference
16 April 2010
1 reference
1 reference
150
1 reference
1
1 reference
58-71
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference